Amryt Pharma plc (NasdaqGM: AMYT)
Health Care · Pharmaceuticals · IE
$—
— today · — 1Y
Amryt Pharma plc (NasdaqGM: AMYT) operates in the Pharmaceuticals industry within the Health Care sector.
Tweenvest scores Amryt Pharma plc across four factors: quality 60/100, value 71/100. Its strongest factor is value.
AMYT price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- —
- Revenue (TTM)
- $243.62M
- P/E
- —
- EPS
- -0.01
- Dividend yield
- —
- Beta (5Y)
- —
- 52-week high
- $—
- 52-week low
- $—
- Avg volume (3M)
- —
- Shares outstanding
- —
- Employees
- 289
- Next earnings
- —
About Amryt Pharma plc
Amryt Pharma plc is a commercial-stage biopharmaceutical company committed to enhancing the lives of individuals with rare and orphan diseases. The firm achieves this by acquiring, developing, and bringing to market specialized therapies. Among its current offerings, Amryt provides: Metreleptin, prescribed as a dietary adjunct and replacement therapy, addresses complications arising from leptin deficiency in patients with congenital or acquired generalized lipodystrophy. Oral octreotide serves as a long-term maintenance solution for those with acromegaly. Lomitapide, used in conjunction with a low-fat diet and other lipid-lowering medications, aids adults diagnosed with Homozygous familial Hypercholesteraemia. Its pipeline features promising investigational therapies, including Oleogel-S10, which targets the skin manifestations of Junctional and Dystrophic Epidermolysis Bullosa (EB)—a severe and uncommon genetic skin disorder impacting both children and adults. Additionally, AP103 is a pre-clinical gene therapy under development for dystrophic EB. Amryt's products are distributed across the Americas, Europe, and the Middle East. Established in 2015, Amryt Pharma plc maintains its headquarters in Dublin, Ireland.
- ISIN
- US03217L1061
- Founded
- 2015
- Listed since
- Jul 8, 2020
- Exchange
- Nasdaq Global Market
- Currency
- USD
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Regnum Corp.OTCPK: RGMP | $23.00 | $— | — |
| CanaQuest Medical Corp.OTCPK: CANQ.F | $21.00 | $— | — |
| The Greenrose Holding Company Inc.OTCPK: GNRS.Q | $18.00 | $— | — |
| Lowell Farms Inc.OTCPK: LOWL.F | $18.00 | $0.00 | — |
| West Island Brands Inc.OTCPK: WIBF.F | $17.00 | $0.00 | — |
| 9 Meters Biopharma, Inc.OTCPK: NMTR.Q | $14.00 | $— | — |
| Biostar Pharmaceuticals, Inc.OTCPK: BSPM | $3.00 | $0.00 | — |
| BC Craft Supply Co. Ltd.OTCPK: CRFT.F | $2.00 | $— | — |
Figures last refreshed Oct 11, 2026.